Cargando…
Chaperone Sigma1R and Antidepressant Effect
This review analyzes the current scientific literature on the role of the Sigma1R chaperone in the pathogenesis of depressive disorders and pharmacodynamics of antidepressants. As a result of ligand activation, Sigma1R is capable of intracellular translocation from the endoplasmic reticulum (ER) int...
Autores principales: | Voronin, Mikhail V., Vakhitova, Yulia V., Seredenin, Sergei B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582751/ https://www.ncbi.nlm.nih.gov/pubmed/32992988 http://dx.doi.org/10.3390/ijms21197088 |
Ejemplares similares
-
Involvement of Chaperone Sigma1R in the Anxiolytic Effect of Fabomotizole
por: Voronin, Mikhail V., et al.
Publicado: (2021) -
Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection
por: Voronin, Mikhail V., et al.
Publicado: (2023) -
Pharmacological Analysis of GABA(A) Receptor and Sigma1R Chaperone Interaction: Research Report I―Investigation of the Anxiolytic, Anticonvulsant and Hypnotic Effects of Allosteric GABA(A) Receptors’ Ligands
por: Voronin, Mikhail V., et al.
Publicado: (2023) -
Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson’s disease
por: Voronin, Mikhail V., et al.
Publicado: (2019) -
Deferred Administration of Afobazole Induces Sigma1R-Dependent Restoration of Striatal Dopamine Content in a Mouse Model of Parkinson’s Disease
por: Kadnikov, Ilya A., et al.
Publicado: (2020)